The relation between BTK expression and iron accumulation of myeloid cells in multiple sclerosis.

Autor: Steinmaurer, Anja, Riedl, Christian, König, Theresa, Testa, Giulia, Köck, Ulrike, Bauer, Jan, Lassmann, Hans, Höftberger, Romana, Berger, Thomas, Wimmer, Isabella, Hametner, Simon

Publikováno v: Brain Pathology; Sep2024, Vol. 34 Issue 5, p1-13, 13p

The protein defective in X-linked agammaglobulinemia, Bruton's tyrosine kinase, shows increased autophosphorylation activity in vitro when isolated from cells in which the B cell receptor has been cross-linked.

Autor: Hinshelwood S; Molecular Immunology Unit, Institute of Child Health, London, GB., Lovering RC, Genevier HC, Levinsky RJ, Kinnon C

Publikováno v: European journal of immunology [Eur J Immunol] 1995 Apr; Vol. 25 (4), pp. 1113-6.

Outcomes of X-Linked Agammaglobulinaemia Patients.

Autor: Shillitoe B; Sheffield Children's NHS Foundation Trust, Sheffield, UK. Benjamin.shillitoe@nhs.net., Duque JSR; Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China., Lai SHY; Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China., Lau TM; Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China., Chan JCH; Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China., Bourne H; Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK., Stroud C; Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK., Flood T; Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK., Buckland M; Institute of Child Health, UCL, London, UK.; University College London, London, UK., Ip W; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., Worth A; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., Hackett S; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Herwadkar A; Salford Care Organisation, Northern Care Alliance NHS Trust, Manchester, UK., Coulter T; Belfast Health and Social Care Trust, Belfast, UK., Blaney C; Belfast Health and Social Care Trust, Belfast, UK., Jolles S; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK., Garcez T; Manchester University NHS Foundation Trust, Manchester, UK., Moya E; Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK., Faust S; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.; Faculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK., Pearce MS; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK., Lau YL; Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China. lauylung@hku.hk., Gennery AR; Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK.; Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Publikováno v: Journal of clinical immunology [J Clin Immunol] 2024 Nov 14; Vol. 45 (1), pp. 40. Date of Electronic Publication: 2024 Nov 14.

Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical.

Autor: Dong, Rong, Yan, Youyou, Zeng, Xiaokang, Lin, Nengming, Tan, Biqin

Publikováno v: Drug Design, Development & Therapy; Sep2022, Vol. 16, p3225-3239, 15p

BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future.

Autor: Spaargaren, M¹, de Rooij, M F M², Kater, A P³, Eldering, E⁴

Publikováno v: Oncogene. 5/7/2015, Vol. 34 Issue 19, p2426-2436. 11p. 3 Diagrams, 1 Chart.